Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763795
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and QOL in Individuals With Type 2 DiabetesSuperior UniversityActive Not RecruitingNot Applicable
NCT07763795Active Not Recruiting
Not Applicable
Effects of BFRT on Glycemic Control, Nerve Conduction, Functional Outcomes and Q...Superior University
NCT07764263
Contextualizing Care for Patients With a Serious IllnessRadboud University Medical CenterCompletedNot Applicable
NCT07764263Completed
Not Applicable
Contextualizing Care for Patients With a Serious IllnessRadboud University Medica...
NCT07761936
Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor FluctuationsUniversita di VeronaRecruitingPhase 3
NCT07761936Recruiting
Phase 3
Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fl...Universita di Verona
NCT07762690
Mechanism-Based Cervical Rehabilitation for Chronic MigraineBeni-Suef UniversityNot Yet RecruitingNot Applicable
NCT07762690Not Yet Recruiting
Not Applicable
Mechanism-Based Cervical Rehabilitation for Chronic MigraineBeni-Suef University
NCT07763158
Evaluating the Role of Genicular Artery Embolization in Treatment of Persistent Pain in Patients With Severe Knee OsteoarthritisKing Abdullah International Medical Research CenterRecruitingNot Applicable
NCT07763158Recruiting
Not Applicable
Evaluating the Role of Genicular Artery Embolization in Treatment of Persistent...King Abdullah Internation...
NCT07763483
Do Endocrine Disruptors Accumulate in Children Undergoing Paediatric Dialysis?Hospices Civils de LyonNot Yet Recruiting
NCT07763483Not Yet Recruiting
—
Do Endocrine Disruptors Accumulate in Children Undergoing Paediatric Dialysis?Hospices Civils de Lyon
NCT07762313
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury.Humacyte, Inc.Not Yet RecruitingPhase 3
NCT07762313Not Yet Recruiting
Phase 3
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular...Humacyte, Inc.
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07763912
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.ADIUMCompletedNot Applicable
NCT07763912Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07762482
Periodontal Tissue Stability After Surgical Correction of Altered Passive EruptionUniversity of Sao PauloRecruitingNot Applicable
NCT07762482Recruiting
Not Applicable
Periodontal Tissue Stability After Surgical Correction of Altered Passive Erupti...University of Sao Paulo
NCT07762573
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective StudyNanfang Hospital, Southern Medical UniversityRecruiting
NCT07762573Recruiting
—
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment i...Nanfang Hospital, Souther...
NCT07764354
How Patient Education Helps Patients With Chronic Musculoskeletal Disorders Stick to Home Exercise for Pain Relief.Imam Abdulrahman Bin Faisal UniversityRecruitingNot Applicable
NCT07764354Recruiting
Not Applicable
How Patient Education Helps Patients With Chronic Musculoskeletal Disorders Stic...Imam Abdulrahman Bin Fais...
NCT07763951
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763951Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07763743
Efficacy and Safety of Flexible Ureteroscopy With Flexible Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy With Vacuum-Assisted Access SheathAin Shams UniversityRecruitingNot Applicable
NCT07763743Recruiting
Not Applicable
Efficacy and Safety of Flexible Ureteroscopy With Flexible Navigable Suction Ure...Ain Shams University
NCT07762768
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With PrediabetesCSIR National Institute for Interdisciplinary Science and Technology (NIIST), ThiruvananthapuramNot Yet RecruitingNot Applicable
NCT07762768Not Yet Recruiting
Not Applicable
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Res...CSIR National Institute f...
NCT07763093
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Class I Gingival RecessionUniversity of Medicine and Pharmacy at Ho Chi Minh CityActive Not RecruitingNot Applicable
NCT07763093Active Not Recruiting
Not Applicable
Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Cla...University of Medicine an...
NCT07762547
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.Beijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07762547Not Yet Recruiting
Not Applicable
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moy...Beijing Tiantan Hospital
NCT07763730
Effects of Robotic Pet and Video-Based Distraction on Pain, Fear, and Anxiety in Children During VenipunctureAkdeniz UniversityCompletedNot Applicable
NCT07763730Completed
Not Applicable
Effects of Robotic Pet and Video-Based Distraction on Pain, Fear, and Anxiety in...Akdeniz University
NCT07762911
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)University Hospital, Basel, SwitzerlandRecruitingNot Applicable
NCT07762911Recruiting
Not Applicable
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year...University Hospital, Base...
NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762703Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metasta...BreakBio Corp
Result Breakdown
Recruiting7 (35%)
Not yet recruiting7 (35%)
Completed4 (20%)
Active, not recruiting2 (10%)
not_applicable14 (70%)
Phase 32 (10%)
Not Specified2 (10%)
Phase 41 (5%)
Phase 11 (5%)